Tuesday, September 18, 2018
 
 
Company News: Page (1) of 1 - 03/20/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Tetraphase Pharmaceuticals to Present at 17th Annual Needham Healthcare Conference

(March 20, 2018)

WATERTOWN, Mass., March 20, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced that company management will give a corporate presentation at the 17th Annual Needham Healthcare Conference on Tuesday, March 27 at 11:00 a.m. Eastern Time at the Westin New York Grand Central Hotel in New York City.

Live audio webcasts of the presentation will be available on the company’s website at http://ir.tphase.com/events.cfm. Archived presentations will be available for 30 days.

About Tetraphase Pharmaceuticals, Inc.

Tetraphase is a biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening bacterial infections, including those caused by many of the multi-drug resistant pathogens highlighted as urgent public health threats by the Centers for Disease Control and Prevention. Tetraphase has created more than 3,000 novel tetracycline analogs using its proprietary technology platform. Tetraphase's pipeline includes three antibiotic clinical candidates: eravacycline, which has completed phase 3 clinical trials and is under review for potential approval in complicated intra-abdominal infections by the United States Food and Drug Administration and the European Medicines Agency, and TP-271 and TP-6076, which are in phase 1 clinical trials. Eravacycline is an investigational product only and has not been approved for commercialization. Please visit www.tphase.com for more company information.

Investor Contact:Argot Partners


Maeve Conneighton
206.899.4940
[email protected]                                                                                                                     

Media Contact:
Sam Brown Inc.
Mike Beyer
312-961-2502
[email protected]


Page: 1


Related Keywords:
Related Sites: Digital Producer ,   Audio Video Producer ,   Presentation Master ,   Oceania ,   DMN Newswire ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: DMN Newsletter ,   CMN Newsletter ,   KNews Newsletter ,   Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Brain Ischemia Market Analysis 2018-2023 | Increased Prevalence Rate with Topmost Players ThromboGenics, Vernalis, Neurotec Pharma, Covidien and Others - Asserts MRFR
  • Effie Chow Qigong Healing System Available On Mediterranean Celebrity Cruise Line Says Sharon Kleyne & Rose Hong
  • The Methuselah Foundation Successfully Closes its Boutique Venture Fund, the Methuselah Fund, Focused on Companies That Can Extend the Healthy Human Lifespan
  • Report on CPH by Research Dynamics: Investor Day update
  • Icahn School of Medicine Celebrates 50th Anniversary with Launch of Scientific American Custom Media Series

    Cancer
  • Sequana Medical reports positive data on use of the alfapump® in malignant ascites patients at the International Gynecologic Cancer Society
  • China Scar Treatment Market to be Valued at USD 2.77 Billion by 2025 | Hexa Research
  • Achieve Announces Positive Cytisine Data Published in International Journal of Drug Policy
  • Hair Care Industry to account for Upsurge Accruals USD 55,756.1 million till 2023 - Confirms MRFR
  • CHI Franciscan Health, Virginia Mason Announce Plan for New Birth Center in Seattle
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines